Moderna Coronavirus Vaccine Won't Be Available Before Election Day, CEO Says

Dealing a blow to President Trump's hope to have a vaccine before Election Day, Moderna's (NASDAQ:MRNA) CEO said the company's coronavirus vaccine won't be ready by Nov. 3.

Speaking at a Financial Times-organized biotech and pharmaceutical conference, Stephane Bancel said that "November 25 is the time we will have enough safety data to be able to put into an EUA [Emergency Use Authorization] file that we would send to the FDA — assuming that the safety data is good, i.e., a vaccine is deemed to be safe."